Cogent Biosciences COGT
NASDAQ COGT
$29.56 -2.08 (-6.57%)
As of: Nov 11, 2026 · 12:40 PM EST

Cogent Biosciences (COGT) Return on Assets [ROA] (2018 - 2026)

Updated

Cogent Biosciences (COGT) posted Return on Assets [ROA] of -42.57% for Q2 2026, up 59.83 percentage points from -102.40% a year earlier but down 4.87 percentage points from the prior quarter.

Analysis

Cogent Biosciences (COGT) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Cogent Biosciences' Return on Assets [ROA] came in at -50.85%, up 29.56 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +3.79 percentage points (FY2020 to FY2025).
  • In prior years, Cogent Biosciences' Return on Assets [ROA] was -80.41% in FY2024 (-16.90 pp), -63.51% in FY2023 (-9.52 pp), -53.99% in FY2022 (-22.90 pp) and -31.09% in FY2021 (+23.55 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -102.40% in Q2 2025 to a high of -27.45% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of -0.13 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2026, with a gain of 59.83 percentage points; the weakest was Q2 2025, with a drop of 52.28 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -37.70% (Q1 2026), -47.19% (Q4 2025) and -84.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Cogent Biosciences 5.50 Bn 2.15 Bn - -49.03%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -49.03%
Jun 30, 2026 -43.51%
Mar 31, 2026 -38.56%
Dec 31, 2025 -48.26%
Sep 30, 2025 -84.21%
Jun 30, 2025 -101.63%
Mar 31, 2025 -88.05%
Dec 31, 2024 -71.82%
Sep 30, 2024 -59.27%
Jun 30, 2024 -50.14%
Mar 31, 2024 -53.76%
Dec 31, 2023 -57.43%
Sep 30, 2023 -47.52%
Jun 30, 2023 -48.03%
Mar 31, 2023 -52.54%
Dec 31, 2022 -44.39%
Sep 30, 2022 -36.04%
Jun 30, 2022 -38.25%
Mar 31, 2022 -41.54%
Dec 31, 2021 -32.29%
API Access

Cogent Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=COGT&period=max&api_key=YOUR_API_KEY